ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

Home
Screener
EXEL
profile

EXEL Company Profile and Key Details

NASDAQ : EXEL

Exelixis, Inc.

$37.65

0.12+0.32%

At Close 4:00 PM

65.15

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

EXEL Stock Price Chart

Stock Price Today

Exelixis, Inc. (EXEL) stock surged +0.32%, trading at $37.65 on NASDAQ, up from the previous close of $37.53. The stock opened at $37.64, fluctuating between $37.62 and $38.42 in the recent session.

Stock Snapshot

37.53

Prev. Close

37.64

Open

10.54B

Market Cap

279.88M

Number of Shares

37.615

Day Low

38.42

Day High

21.39

P/E Ratio

97.3%

Free Float in %

1.76

EPS (TTM)

7.34

Book Value

0.55

Cash Flow per Share

2.45M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 27, 2025	37.61	38.43	37.60	37.65	2.52M
Feb 26, 2025	37.05	37.64	36.95	37.53	2M
Feb 25, 2025	37.25	37.57	36.16	36.92	2.41M
Feb 24, 2025	36.39	37.24	36.06	37.13	3.35M
Feb 21, 2025	36.10	37.05	35.88	36.85	3.49M
Feb 20, 2025	34.95	35.17	34.50	35.09	1.78M
Feb 19, 2025	34.16	35.46	34.07	35.07	2.81M
Feb 18, 2025	35.08	35.37	34.01	34.20	2.49M
Feb 14, 2025	34.37	35.29	34.18	35.00	2.86M
Feb 13, 2025	32.92	34.60	32.84	34.49	3.54M
Feb 12, 2025	33.20	35.37	32.72	32.80	4.91M
Feb 11, 2025	33.38	33.61	32.40	32.81	2.18M
Feb 10, 2025	33.55	34.24	33.42	33.50	2.51M
Feb 07, 2025	33.60	33.80	33.10	33.48	1.49M
Feb 06, 2025	33.57	33.87	33.35	33.67	1.58M
Feb 05, 2025	33.39	33.60	33.21	33.55	1.57M
Feb 04, 2025	33.35	33.60	32.95	33.12	1.55M
Feb 03, 2025	32.80	33.33	32.44	32.88	1.98M
Jan 31, 2025	32.92	33.65	32.92	33.15	2.42M
Jan 30, 2025	33.22	33.32	32.74	32.93	2.15M

Contact Details

Alameda, CA 94502

United States

Website: https://www.exelixis.comContact: 650 837 7000

About Company

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Frequently Asked Questions

What is the current Exelixis, Inc. (EXEL) stock price?

Exelixis, Inc. (NASDAQ: EXEL) stock price is $37.65 in the last trading session. During the trading session, EXEL stock reached the peak price of $38.42 while $37.62 was the lowest point it dropped to. The percentage change in EXEL stock occurred in the recent session was 0.32% while the dollar amount for the price change in EXEL stock was $0.12.

EXEL's industry and sector of operation?

The NASDAQ listed EXEL is part of Biotechnology industry that operates in the broader Healthcare sector. Exelixis, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EXEL?

Ms. Susan T. Hubbard
Executive Vice President of Public Affairs & Investor Relations
Dr. Dana T. Aftab Ph.D.
Executive Vice President of Discovery and Translational Research & Chief Scientific Officer
Ms. Laura Dillard
Executive Vice President of HR
Mr. Christopher J. Senner
Executive Vice President & Chief Financial Officer
Mr. Patrick J. Haley M.B.A., MBA
Executive Vice President of Commercial
Mr. Jeffrey J. Hessekiel J.D.
Executive Vice President, Gen. Counsel & Sec.
Dr. Peter Lamb Ph.D.
Executive Vice President of Scientific Strategy & Chief Scientific Officer
Dr. Michael M. Morrissey Ph.D.
Chief Executive Officer, Pres & Director
Mr. Gregg Bernier
Vice President of Marketing
Dr. Stelios Papadopoulos Ph.D.
Co-Founder & Independent Chair of the Board
Dr. Vicki L. Goodman M.D.
Executive Vice President of Product Devel. & Medical Affairs and Chief Medical Officer

How EXEL did perform over past 52-week?

EXEL's closing price is 86.94% higher than its 52-week low of $20.14 where as its distance from 52-week high of $38.42 is -2%.

How many employees does EXEL have?

Number of EXEL employees currently stands at 1,147.

Link for EXEL official website?

Official Website of EXEL is: https://www.exelixis.com

How do I contact EXEL?

EXEL could be contacted at phone 650 837 7000 and can also be accessed through its website. EXEL operates from 1851 Harbor Bay Parkway, Alameda, CA 94502, United States.

How many shares of EXEL are traded daily?

EXEL stock volume for the day was 2.45M shares. The average number of EXEL shares traded daily for last 3 months was 2.39M.

What is the market cap of EXEL currently?

The market value of EXEL currently stands at $10.54B with its latest stock price at $37.65 and 279.88M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

EXEL Stock Price Chart

Stock Price Today

Exelixis, Inc. (EXEL) stock surged +0.32%, trading at $37.65 on NASDAQ, up from the previous close of $37.53. The stock opened at $37.64, fluctuating between $37.62 and $38.42 in the recent session.

Stock Snapshot

37.53

Prev. Close

37.64

Open

10.54B

Market Cap

279.88M

Number of Shares

37.615

Day Low

38.42

Day High

21.39

P/E Ratio

97.3%

Free Float in %

1.76

EPS (TTM)

7.34

Book Value

0.55

Cash Flow per Share

2.45M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 27, 2025	37.61	38.43	37.60	37.65	2.52M
Feb 26, 2025	37.05	37.64	36.95	37.53	2M
Feb 25, 2025	37.25	37.57	36.16	36.92	2.41M
Feb 24, 2025	36.39	37.24	36.06	37.13	3.35M
Feb 21, 2025	36.10	37.05	35.88	36.85	3.49M
Feb 20, 2025	34.95	35.17	34.50	35.09	1.78M
Feb 19, 2025	34.16	35.46	34.07	35.07	2.81M
Feb 18, 2025	35.08	35.37	34.01	34.20	2.49M
Feb 14, 2025	34.37	35.29	34.18	35.00	2.86M
Feb 13, 2025	32.92	34.60	32.84	34.49	3.54M
Feb 12, 2025	33.20	35.37	32.72	32.80	4.91M
Feb 11, 2025	33.38	33.61	32.40	32.81	2.18M
Feb 10, 2025	33.55	34.24	33.42	33.50	2.51M
Feb 07, 2025	33.60	33.80	33.10	33.48	1.49M
Feb 06, 2025	33.57	33.87	33.35	33.67	1.58M
Feb 05, 2025	33.39	33.60	33.21	33.55	1.57M
Feb 04, 2025	33.35	33.60	32.95	33.12	1.55M
Feb 03, 2025	32.80	33.33	32.44	32.88	1.98M
Jan 31, 2025	32.92	33.65	32.92	33.15	2.42M
Jan 30, 2025	33.22	33.32	32.74	32.93	2.15M

Contact Details

Alameda, CA 94502

United States

Website: https://www.exelixis.comContact: 650 837 7000

About Company

Frequently Asked Questions

What is the current Exelixis, Inc. (EXEL) stock price?

EXEL's industry and sector of operation?

Who are the executives of EXEL?

How EXEL did perform over past 52-week?

EXEL's closing price is 86.94% higher than its 52-week low of $20.14 where as its distance from 52-week high of $38.42 is -2%.

How many employees does EXEL have?

Number of EXEL employees currently stands at 1,147.

Link for EXEL official website?

Official Website of EXEL is: https://www.exelixis.com

How do I contact EXEL?

EXEL could be contacted at phone 650 837 7000 and can also be accessed through its website. EXEL operates from 1851 Harbor Bay Parkway, Alameda, CA 94502, United States.

How many shares of EXEL are traded daily?

EXEL stock volume for the day was 2.45M shares. The average number of EXEL shares traded daily for last 3 months was 2.39M.

What is the market cap of EXEL currently?

The market value of EXEL currently stands at $10.54B with its latest stock price at $37.65 and 279.88M of its shares outstanding.

Employees	1147
Beta	0.53
Sales or Revenue	$1.83B
5Y Sales Change%	1.007%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	1147
Beta	0.53
Sales or Revenue	$1.83B
5Y Sales Change%	1.007%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

EXEL Company Profile and Key Details

Exelixis, Inc.

EXEL Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

EXEL Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions